COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   Latest News   »   PDA submits evidence to the Public Accounts Committee Inquiry on reducing the harm from illegal drugs

PDA submits evidence to the Public Accounts Committee Inquiry on reducing the harm from illegal drugs

The PDA recently submitted written evidence to the Public Accounts Committee (PAC) specifically to draw attention to the impact on patients of temporary pharmacy closures and who therefore cannot access treatment supporting their recovery from the use of illegal drugs.

Thu 1st February 2024 The PDA

The Public Accounts Committee (PAC) accepted and published 22 written submissions in their call for evidence, including the evidence submitted by the PDA. The PDA’s evidence focused on one aspect that the PAC is interested in. The focus of the PDA’s submission was the barrier created for patients to access treatment and support recovery when a pharmacy closed temporarily.

The PDA has been actively bringing to the attention of policymakers and legislators the impact that temporary pharmacy closures have on patients. This impact can often affect the most vulnerable patients. Pharmacies with an NHS contract have a contractual obligation to observe their opening hours as part of their agreement with the NHS to provide a continuity of pharmaceutical services to their local neighbourhoods.

For this particular inquiry, the PDA wanted to draw to the attention of the PAC published information together with data that the PDA had received from Freedom of Information requests which showed the wide scale and GB-wide nature of temporary pharmacy closures. The PDA also wanted to bring to the attention of the inquiry the disproportionate number of temporary closures which could be attributed to members of the largest chains (those represented by the Company Chemists Association).

The PDA highlighted the unique nature of the service that pharmacists provide, including their role in supervising methadone consumption by patients on a daily basis. Pharmacists ensure that individuals who are accessing treatment to support their recovery from addiction to illegal drugs can do so in a safe and appropriate environment.

The evidence included information about the special storage, handling, and record-keeping requirements for controlled drugs and that many pharmacies did not routinely keep any stock of these special items. The PDA included examples from published sources around the impact on individuals when access to lawful supplies of controlled drugs was interrupted (even if that interruption was for one single day).

The work of the Public Account Committee Inquiry can be found here.

The PDA’s evidence can be found here.

Learn more

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists, and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)